China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m
China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m Source: Laurynas Mereckas/Unsplash May 6, 2021 Chinese innovative drug developer Hope Medicine has secured $56 million in a funding round led by investment firms Qiming Venture Partners and Grand Flight Investment, while biotech firm Yikon Genomics has raised 250 million yuan ($38.6 million). Qiming, Grand Flight lead $56m round in drug maker Hope Chinese drug developer Hope Medicine has secured $56 million in a Series B round of financing jointly led by investment firms Qiming Venture Partners and Grand Flight Invest...
Source: dealstreetasia.com